Oxford University explores anti-parasitic drug ivermectin as COVID-19 treatment

Ivermectin resulted in a reduction of virus replication in laboratory studies, the university said, adding that a small pilot showed giving the drug early could reduce viral load and the duration of symptoms in some patients with mild COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gUqL6p
via IFTTT